Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:23 Feb 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1182.75 [ -2.05% ]TCS 2481.80 [ +2.92% ]

Sensex28892.97
28.26 0.10%

Nifty8939.50
12.60 0.14%

Midcap13532.11
25.18 0.19%

Smallcap13587.78
14.75 0.11%



Alembic Pharmaceuticals Ltd :

 571.50  -11.70 [-2.01%]

ISIN: INE901L01018  | NSE: APLLTD |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 533573  |  Add To Watchlist

Price Information
• Open 588.00
• High 588.00
• Low 568.60
• Previous Close 583.20
• Shares Traded 1273400
• 52 Wk High Price 699.50
• 52 Wk High Date 05-10-2016
• 52 Wk Low Price 515.55
• 52 Wk Low Date 18-04-2016
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 11180.90
• EPS (Rs.)(TTM) 24.41
• P/E Ratio(TTM) 24.29
• Book Value (Rs.) 81.20
• Price to Book Value 7.30
• Equity (Rs.cr.) 37.70
• Traded Value (Rs.lac) 44.59


Corporate Actions
Ex-Date Purpose (Rs.)
2012-07-31 70% Dividend (1.4)
2013-07-29 125% Dividend (2.5)
2014-07-17 150% Dividend (3)
2015-07-22 175% Dividend (3.5)
2016-07-20 200% Dividend (4)


Index Names
BSE HC
BSE Small Cap
BSE-200
BSE-500


Related Companies
Stock Name Price
BAJAJTEMPO 4205.35




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 797.63 2920.36 2991.74
• Net Profit (Rs.cr) 137.83 460.19 698.14
• Net Profit Var (%) -51.00 -32.00 144.00
• EPS (Rs) - 24.41 37.00
• P/E Ratio - 24.29 16.00
• Operating Profit Margin - 23.04 -
• CPS (Rs.) - - 40.90
• P/C Ratio - - 14.50
• Div% - - 200.00

Announcements
28-04-2016 Board of Alembic Pharmaceuticals recommends final dividend
29-06-2012 Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine (Prist
15-06-2012 Alembic Pharma settles patent litigation with Novartis for generic version of Exelon
18-11-2016 Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets
05-12-2016 Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets
22-10-2012 Alembic Pharmaceuticals received final approval for Modfinil tablets
16-12-2016 Alembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules
02-05-2016 Alembic Pharmaceuticals receives final approval for Lacosamide Tablets
05-07-2016 Alembic Pharmaceuticals receives tentative approval for Febuxostat Tablets
03-05-2013 Alembic Pharmaceuticals Recommends Dividend
12-04-2012 Alembic Pharmaceuticals to consider dividend
05-06-2014 Alembic Pharmaceuticals to hold AGM
26-09-2014 Alembic Pharmaceuticals to hold board meeting
21-04-2016 Alembic Pharmaceuticals to set up JV with Orbicular
27-04-2015 Board of Alembic Pharmaceuticals appoints directors
10-01-2017 Board of Alembic Pharmaceuticals to consider Q3 results
28-07-2014 Outcome of board meeting of Alembic Pharmaceuticals

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
23-02-2017 7195 12734 56.50 4111943 7322.13
22-02-2017 891 1636 54.46 519632 956.02
21-02-2017 4174 7608 54.86 2475809 4459.44
20-02-2017 10861 23609 46.00 6327619 13523.90
17-02-2017 2680 3509 76.38 1480432 1940.33


Block Deals
Deal Date Client Name Type Qty Price
19-05-2015 CRESTA FUND LIMITED B 620000 512.00
19-05-2015 LOTUS GLOBAL INVESTMENT LIMITED S 620000 512.00


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  classic global finance  •  tata motor  •  eicher motor  •  unity infra  •  chemical
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech